- Home
- VCEL vs KRP Comparison
VCEL vs KRP Comparison
Compare VCEL & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCEL | KRP |
|---|---|---|
| Founded | 1989 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | VCEL | KRP |
|---|---|---|
| Price | $35.76 | $14.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $57.75 | $17.33 |
| AVG Volume (30 Days) | 557.8K | ★ 693.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 10.76% |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $333,830,000.00 |
| Revenue This Year | $19.40 | $6.88 |
| Revenue Next Year | $18.24 | N/A |
| P/E Ratio | $106.89 | ★ N/A |
| Revenue Growth | ★ 16.45 | 7.93 |
| 52 Week Low | $28.95 | $11.31 |
| 52 Week High | $45.97 | $15.12 |
Technical Indicators
Market Signals| Indicator | VCEL | KRP |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 54.61 |
| Support Level | $34.26 | $14.11 |
| Resistance Level | $38.48 | $15.01 |
| Average True Range (ATR) | 1.31 | 0.27 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 94.02 | 64.36 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About KRP Kimbell Royalty Partners
Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.